Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flucelvax in healthy volunteers (influenza challenge)
NCT03845231Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Apr 2019
- Primary completion
- Dec 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Fluzone Trivalent in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Started Apr 2019; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03845231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03845231.